BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17520872)

  • 21. Oral balsalazide (Colazal) for ulcerative colitis.
    Med Lett Drugs Ther; 2001 Jul; 43(1109):62-3. PubMed ID: 11468602
    [No Abstract]   [Full Text] [Related]  

  • 22. Review article: the management of steroid dependency in ulcerative colitis.
    Bianchi Porro G; Cassinotti A; Ferrara E; Maconi G; Ardizzone S
    Aliment Pharmacol Ther; 2007 Sep; 26(6):779-94. PubMed ID: 17767462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rebamipide enema therapy as a treatment for patients with active distal ulcerative colitis.
    Furuta R; Ando T; Watanabe O; Maeda O; Ishiguro K; Ina K; Kusugami K; Goto H
    J Gastroenterol Hepatol; 2007 Feb; 22(2):261-7. PubMed ID: 17295881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of acute crisis of ulcerative colitis].
    Herrerias Gutiérrez JM; Pérez Ruilópez MA; Pellicer Bautista FJ; Garrido Peralta M
    Rev Esp Enferm Apar Dig; 1977 Jun; 50(5):541-8. PubMed ID: 887850
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treating distal ulcerative colitis intrarectally. Foam instead of enema, low volume rather than high volume].
    MMW Fortschr Med; 2008 Apr; 150(15):44. PubMed ID: 18510119
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical trial: randomized-controlled clinical study comparing the efficacy and safety of a low-volume vs. a high-volume mesalazine foam in active distal ulcerative colitis.
    Eliakim R; Tulassay Z; Kupcinskas L; Adamonis K; Pokrotnieks J; Bar-Meir S; Lavy A; Mueller R; Greinwald R; Chermesh I; Gross V;
    Aliment Pharmacol Ther; 2007 Nov; 26(9):1237-49. PubMed ID: 17944738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical corticosteroids in inflammatory bowel disease.
    Mulder CJ; Rondas AA; Wiltink EH; Tytgat GN
    Neth J Med; 1989 Jun; 35 Suppl 1():S27-34. PubMed ID: 2702309
    [No Abstract]   [Full Text] [Related]  

  • 28. Mesalamine foam enema versus mesalamine liquid enema in active left-sided ulcerative colitis.
    Cortot A; Maetz D; Degoutte E; Delette O; Meunier P; Tan G; Cazals JB; Dewit O; Hebuterne X; Beorchia S; Grunberg B; Leprince E; D'Haens G; Forestier S; Idier I; Lémann M
    Am J Gastroenterol; 2008 Dec; 103(12):3106-14. PubMed ID: 19086960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current pharmacologic therapies and emerging alternatives in the treatment of ulcerative colitis.
    Nakamura T; Nagahori M; Kanai T; Watanabe M
    Digestion; 2008; 77 Suppl 1():36-41. PubMed ID: 18204260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A review of infliximab use in ulcerative colitis.
    Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
    Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Infliximab in active ulcerative colitis -- proven efficacy as induction and maintenance treatment].
    Heidemann J; Kucharzik TF
    Z Gastroenterol; 2006 Jun; 44(6):540-2. PubMed ID: 16773520
    [No Abstract]   [Full Text] [Related]  

  • 32. Medical treatment and management of severe ulcerative colitis.
    Rizzello F; Campieri M; Tambasco R; Straforini G; Brugnera R; Poggioli G; Gionchetti P
    Dig Liver Dis; 2008 Jul; 40 Suppl 2():S280-4. PubMed ID: 18599001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sucralfate enema (SUC)--effective in IBD?
    Carling L; Kagevi I; Borvall E
    Endoscopy; 1986 May; 18(3):115. PubMed ID: 3755100
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical trials in ulcerative colitis: II. Historical review.
    Margolin ML; Krumholz MP; Fochios SE; Korelitz BI
    Am J Gastroenterol; 1988 Mar; 83(3):227-43. PubMed ID: 2894170
    [No Abstract]   [Full Text] [Related]  

  • 35. Anti-inflammatory effect of rebamipide enema on proctitis type ulcerative colitis: a novel therapeutic alternative.
    Makiyama K; Takeshima F; Kawasaki H; Zea-Iriarte WL
    Am J Gastroenterol; 2000 Jul; 95(7):1838-9. PubMed ID: 10925999
    [No Abstract]   [Full Text] [Related]  

  • 36. Budesonide rectal foam (Uceris) for ulcerative colitis.
    Med Lett Drugs Ther; 2015 Nov; 57(1481):154. PubMed ID: 26529134
    [No Abstract]   [Full Text] [Related]  

  • 37. [TNF-alpha antibody treatment and remission induction in ulcerative colitis: a review of a Cochrane review].
    Bjerrum JT; Munck LC; Krogh-Madsen M; Nielsen OH
    Ugeskr Laeger; 2007 Feb; 169(9):792-5. PubMed ID: 17355842
    [No Abstract]   [Full Text] [Related]  

  • 38. Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids.
    Yamamoto-Furusho JK; Uzcanga LF
    Dig Surg; 2008; 25(5):383-6. PubMed ID: 19005257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proctofoam-HC for anorectal disorders.
    Med Lett Drugs Ther; 1971 Aug; 13(17):69-70. PubMed ID: 5164089
    [No Abstract]   [Full Text] [Related]  

  • 40. Optimizing management of distal ulcerative colitis.
    Nilsson A
    Scand J Gastroenterol; 2006 May; 41(5):511-23. PubMed ID: 16638692
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.